Cargando…

Pharmacotherapies for Diabetic Retinopathy: Present and Future

Diabetic retinopathy remains a major cause of worldwide preventable blindness. Measures to avoid blindness include medical management (control of blood sugar, blood pressure, and serum lipids) and ocular management (laser photocoagulation and pars plana vitrectomy). Adjunctive pharmacologic therapie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwartz, Stephen G., Flynn Jr., Harry W.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2007
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940315/ https://www.ncbi.nlm.nih.gov/pubmed/17713597 http://dx.doi.org/10.1155/2007/52487

Ejemplares similares

Emerging Pharmacotherapies for Diabetic Macular Edema
por: Javey, Golnaz, et al.
Publicado: (2012)

Update on genetics and diabetic retinopathy
por: Hampton, Blake M, et al.
Publicado: (2015)

Novel Pharmacotherapies in Diabetic Retinopathy
por: Dedania, Vaidehi S., et al.
Publicado: (2015)

The Evolving Treatment of Diabetic Retinopathy
por: Mansour, Sam E, et al.
Publicado: (2020)

Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
por: Das, Arup, et al.
Publicado: (2016)

Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
por: Lu, Lei, et al.
Publicado: (2018)

Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
por: Hertanto, Decsa Medika, et al.
Publicado: (2021)

Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future
por: Fike, Candice D., et al.
Publicado: (2023)

Classification of diabetic retinopathy: Past, present and future
por: Yang, Zhengwei, et al.
Publicado: (2022)

Corrigendum to “Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review”
por: Lu, Lei, et al.
Publicado: (2018)

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future
por: Mallik, Ritwika, et al.
Publicado: (2022)

Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
por: Sharma, Anjalee, et al.
Publicado: (2016)

Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma
por: Kitadai, Rui, et al.
Publicado: (2021)

Pharmacotherapies for Obesity: Past, Current, and Future Therapies
por: Ioannides-Demos, Lisa L., et al.
Publicado: (2011)

Endophthalmitis Caused by Agrobacterium radiobacter following Intravitreal Aflibercept for Diabetic Retinopathy
por: Rohowetz, Landon J., et al.
Publicado: (2020)

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future
por: Navarini, Luca, et al.
Publicado: (2020)

Update on corticosteroids for diabetic macular edema
por: Schwartz, Stephen G, et al.
Publicado: (2016)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

Color fundus imaging in retinopathy of prematurity screening: Present and future
por: Jayanna, Sushma, et al.
Publicado: (2023)

Pharmacotherapy for chronic obesity management: a look into the future
por: Abdel-Malek, Mariana, et al.
Publicado: (2023)

Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
por: Cummings, Jeffrey L., et al.
Publicado: (2019)

Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
por: Raghu, Ganesh
Publicado: (2017)

Current and future approaches in the prevention and treatment of diabetic retinopathy
por: Chang, Louis K, et al.
Publicado: (2008)

Laser-induced choroidal neovascularization detected on optical coherence tomography angiography in patients with diabetic retinopathy
por: Iyer, Prashanth G., et al.
Publicado: (2022)

Pars plana vitrectomy for primary rhegmatogenous retinal detachment
por: Schwartz, Stephen G, et al.
Publicado: (2008)

Preventive pharmacotherapy in type 2 diabetes mellitus
por: Choudhary, Neeraj, et al.
Publicado: (2012)

Weight Considerations in Pharmacotherapy for Type 2 Diabetes
por: Cheng, Vicky, et al.
Publicado: (2011)

Progress of Imaging in Diabetic Retinopathy—From the Past to the Present
por: Horie, Shintaro, et al.
Publicado: (2022)

Experiment-Based Interventions to Diabetic Retinopathy: Present and Advances
por: Liu, Siwei, et al.
Publicado: (2022)

Diabetic retinopathy and OCT angiography: clinical findings and future perspectives
por: de Barros Garcia, Jose Mauricio Botto, et al.
Publicado: (2017)

Obesity Pharmacotherapy: Current Perspectives and Future Directions
por: Misra, Monika
Publicado: (2013)

Artificial intelligence in diabetic retinopathy: A natural step to the future
por: Padhy, Srikanta Kumar, et al.
Publicado: (2019)

Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies
por: Rodríguez, María L., et al.
Publicado: (2019)

Review: Machine learning in precision pharmacotherapy of type 2 diabetes—A promising future or a glimpse of hope?
por: Zou, Xiantong, et al.
Publicado: (2023)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update
por: James, Cornelius Fernandez, et al.
Publicado: (2022)

Pharmacotherapy as an adjunct to vitrectomy
por: Villegas, Victor M., et al.
Publicado: (2021)

Pharmacotherapy for Cluster Headache
por: Brandt, Roemer B., et al.
Publicado: (2020)

Current and Future Treatments for Diabetic Retinopathy
por: Behar-Cohen, Francine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b3qbam2o5icftv9hmhqosseqrs